ribavirin has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biasi, L; Casari, S; Castelli, F; Chirico, C; Festa, E; Izzo, I; Salemme, M; Villanacci, V; Zanotti, P | 1 |
| de Silva, K; Jones, BE; Napoli, J; Pang, SH | 1 |
2 other study(ies) available for ribavirin and Colitis
| Article | Year |
|---|---|
Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C.
Topics: Aged; Antiviral Agents; Colitis; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Ribavirin; Simeprevir; Sofosbuvir | 2016 |
A fatal case of phlegmonous colitis in chronic hepatitis C receiving combination interferon and ribavirin therapy.
Topics: Colitis; Drug Therapy, Combination; Fatal Outcome; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Ribavirin | 2009 |